Liraglutide
Product Quick Detail
- Minimum Order
- 1
- Packaging
- N/A
- Delivery
- 15 Days
Specifications
CAS.NO: 204656-20-2
Liraglutide therapy can reduce glycosylated hemoglobin, and it has been shown to be beneficial to cardiovascular treatment in typeⅡ diabetic patients with atherosclerotic cardiovascular disease with coronary heart disease, ischemic stroke, and peripheral artery disease.
Liraglutide Treatment Specifications
Product Name Liraglutide
Packing Specification 10g/100g/500g
Appearances White or off-white powder
Activity: NLT 10Unit
70%~130%
Content: 95.0%~105.0% 95.0%~105.0%
Bacterial Endotoxin Less than 10 EU
Residual HCP NMT 10ng
Residual Exogenous DNA NMT 10ng/dose
Macromolecular Potein NMT 0.7%
HPLC Purity ＞98.0%
Storage Conditions -15℃ below, protected from light, sealed
The data should be subject to test report of products.
Liraglutide Application
Used to prepare liraglutide 3.0 injection.
Liraglutide Insulin Recommended Method
Liraglutide easy dissolved in acidic (pH < 2.5), neutral and alkaline conditions, and can be dissolved and clarified above pH7.0.
Insulin Degludec and Liraglutide Transport and Storage Stability
Transportation stability: It is transported in an ice pack to keep it active.
Storage stability: The product can be stored for at least 24 months at -15°C below.
Notice and Disclaimer
Pollution should be avoided during operation.
The product should not be used for diagnosis or treatment of animals or humans.
If you want to know more about liraglutide in type 1 diabetes, please visit our website.
As one of biopharmaceutical companies, we can offer sorts of pharmaceutical raw materials for sale, anything you need, please leave us a message.
Liraglutide therapy can reduce glycosylated hemoglobin, and it has been shown to be beneficial to cardiovascular treatment in typeⅡ diabetic patients with atherosclerotic cardiovascular disease with coronary heart disease, ischemic stroke, and peripheral artery disease.
Liraglutide Treatment Specifications
Product Name Liraglutide
Packing Specification 10g/100g/500g
Appearances White or off-white powder
Activity: NLT 10Unit
70%~130%Content: 95.0%~105.0% 95.0%~105.0%
Bacterial Endotoxin Less than 10 EU
Residual HCP NMT 10ng
Residual Exogenous DNA NMT 10ng/dose
Macromolecular Potein NMT 0.7%
HPLC Purity ＞98.0%
Storage Conditions -15℃ below, protected from light, sealed
The data should be subject to test report of products.
Liraglutide Application
Used to prepare liraglutide 3.0 injection.
Liraglutide Insulin Recommended Method
Liraglutide easy dissolved in acidic (pH < 2.5), neutral and alkaline conditions, and can be dissolved and clarified above pH7.0.
Insulin Degludec and Liraglutide Transport and Storage Stability
Transportation stability: It is transported in an ice pack to keep it active.
Storage stability: The product can be stored for at least 24 months at -15°C below.
Notice and Disclaimer
Pollution should be avoided during operation.
The product should not be used for diagnosis or treatment of animals or humans.
If you want to know more about liraglutide in type 1 diabetes, please visit our website.
As one of biopharmaceutical companies, we can offer sorts of pharmaceutical raw materials for sale, anything you need, please leave us a message.
- Country: Afghanistan
- Business Type:
- Market:
- Founded Year:
- Address:
- Contact:g- biotec
Other products from Zhuhai Gene-Biocon Biological Technology Co., Ltd.
Relate products of Liraglutide
Saxenda (Liraglutide) 6mg/Ml
Saxenda (liraglutide) is similar to a hormone that occurs naturally in the body and helps control blood sugar, insulin levels, and digestion. Saxenda is an injectable prescription medicine that may help some obese adults or overweight adults, who also have weight related medical ...
